FindTrial
Sign In

Chinese localization of the EORTC QLQ-LC29 scale and clinical validation study in lung cancer patients (CN-PRO-Lung 4)

Validation study of LC29 in Chinese lung cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041514
Enrollment
Unknown
Registered
2020-12-27
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Pilot-testing group:None
Validation group:None

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged over 18 years; 2. Patients with lung cancer confirmed by pathology; 3. Patients who can understand the research content; 4. Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: Patients with a history of other malignancies.

Design outcomes

Primary

MeasureTime frame
comprehensibility;reliability;validity;responsiveness;—

Secondary

MeasureTime frame
Compliance rate;Satisfaction score;—

Countries

China

Contacts

Public ContactDai Wei

Sichuan Cancer Hospital

daiwei@sichuancancer.org+86 18508222758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026